In addition to the production of virus-specific antibodies, virus infection elicits cellular immunity characterized by the expansion of both CD4 ϩ and CD8 ϩ T cells [1] . The antibodies neutralize in a subtype-specific manner, but cellular immunity, because it is generated against immunogenic peptides not subject to selective pressure, is cross-reactive [2].
In addition to the production of virus-specific antibodies, virus infection elicits cellular immunity characterized by the expansion of both CD4 ϩ and CD8 ϩ T cells [1] . The antibodies neutralize in a subtype-specific manner, but cellular immunity, because it is generated against immunogenic peptides not subject to selective pressure, is cross-reactive [2] .
Recovery from virus infection is primarily mediated by cellular immune responses [3, 4] . CD8 ϩ T cells, which have the ability to kill virus-infected cells and prevent the release of progeny virus, certainly are a major contributor to recovery [5, 6] . The role of CD4 ϩ cells is not as clear. CD4 ϩ T cells respond to viral peptides presented on major histocompatibility complex class II molecules by the release of cytokines. The cytokines have diverse functions, including serving as growth factors for CD4 ϩ and CD8 ϩ cells, involvement in the maturation and differentiation of B cells, and inciting inflammation. However, it is notable that many studies have demonstrated that in infected mice lacking CD8 ϩ T cells, a CD4 ϩ -dependent pathway is able to clear virus [1, [7] [8] [9] [10] . In addition, considerable evidence exists that shows that CD4 ϩ cells are also capable of mediating facilitated recovery after adoptive transfer [4, 11, 12] into naïve infected animals. Whether this is mediated by the release of cytokines that accelerate the production of antibodies [8, 13] or cytotoxic T lymphocytes (CTLs), by direct effects of the cytokines on virus-infected cells [14] or by some other mechanism is unknown.
It is now clear that after stimulation, CD4 ϩ T cells can mature into one of at least two subtypes, Th1 or Th2 [15] [16] [17] . Th1 immune responses are characterized by the release of high levels of g-interferon and low levels of interleukin (IL)-4, whereas Th2 responses show the opposite cytokine profile [15, 18] . Th1 responses lead to the generation of CTLs, whereas Th2 responses actually suppress their generation [19] [20] [21] . Antibodies are produced by either pathway, but in the presence of Th1 cells and g-interferon, B cells are induced to class switch to complement-activating isotypes (murine IgG2a) [15, 22] . Non-complement-activating murine IgG1 is the predominant isotype in Th2 responses. We and others have documented that Th1 responses are essential for efficient recovery from virus infection [11, 19, 20] .
The mechanism determining the direction of the response is not clearly defined, although the cytokine environment during the initial interaction of the immune system with the immunogen certainly plays an important role [18, [23] [24] [25] . IL-12 is a cytokine released primarily by professional antigen-presenting cells, which has been documented to induce differentiation to Th1 cells [24, [26] [27] [28] . In contrast, an environment rich in IL-4 leads to Th2 immunity [19, 20, 23, 29] .
Animals immunized with one virus subtype and challenged with another, serologically distinct subtype demonstrate a reduced disease and facilitated recovery that is independent of preformed antibody [2, 30, 31] . This phenomenon, known as heterosubtypic immunity, is mediated by a virus-specific T cell memory response [30] . The evidence that CD8 T cells are of primary importance, although largely circumstantial, is strong and is based on findings that many virus-specific T cells are cross-reactive for heterologous virus subtypes, reflecting their specificity for internal viral proteins [6, 32] . Moreover, adoptive transfer of CD8 ϩ T cells can provide protection in vivo [33] [34] [35] , and immunization with genes for internal viral proteins expressed in vaccinia vectors [36] or as DNA immunizations [37] primes for cross-reactive T cells, which are protective. Live or live, attenuated virus immunization primes for heterosubtypic immunity, but inactivated virus does not [12, 38, 39] . It is generally believed that this results from a failure of inactivated virus to enter into the endogenous pathway and stimulate CTL generation. In light of the ability of CD4 ϩ cells to mediate a facilitated recovery from virus infection when infused into naïve, virus-infected mice [4, 11] , an additional mechanism must be involved. One possibility is that inactivated virus may expand Th2 cells and prime for the wrong type of immunity. Precedent for this has been established in studies investigating the immune response to respiratory syncytial virus (RSV) [40, 41] . These studies have shown that inactivated RSV primes for Th2 immunity, which is reactivated after infection, leading to an atypical immune response that inhibits recovery and results in abnormal lung pathology. Other studies have demonstrated that immunization with inactivated virus and IL-12 leads to facilitated clearance of RSV from the lungs of mice subsequently infected with RSV [42] .
We examined the response of BALB/c mice to inactivated influenza virus and found that indeed it did generate Th2 immunity. We hypothesized that if we immunized with inactivated virus in a Th1 cytokine context (high IL-12, low IL-4), we might be able to generate a Th1 response capable of providing protection against infection with a serologically distinct virus subtype, that is, heterosubtypic immunity. In this report we present our findings and discuss a possible mechanism for the inability of inactivated virus to elicit Th1 immunity. Additionally, we present evidence, obtained from immunized animals, suggesting that once Th2 immunity to a virus is imprinted, it is reactivated after challenge by live virus infection.
Methods and Materials
Viruses. Influenza viruses A/PR8/34 (PR8), H1N1 subtype, and A/HK X-31 (X31), H3N2 subtype, were grown for 40 h in 9-day embryonated eggs at 37ЊC. Allantoic fluid was removed and stored at Ϫ80ЊC.
Cells. Madin-Darby canine kidney cells (MDCKs) and P815 cells were grown in tissue culture medium composed of Dulbecco's MEM (DMEM; Bethesda Research Laboratories, Gaithersburg, MD), 10% fetal calf serum (FCS; Hyclone Laboratories, Logan, UT), 1 mM Na pyruvate (NaPy), 2 mM L-glutamine, and 50 mg/ mL gentamicin (Boehringer Mannheim, Indianapolis). All cells were grown at 37ЊC, 7% CO 2 . All spleen cell cultures were grown in RPMI 1640, 10% FCS, 1 mM NaPy, 2 mM L-glutamine, 50 mg/ mL gentamicin, and M 2-mercaptoethanol (T cell me-
Ϫ5
5 ϫ 10 dium). Virus titration and infections were performed in a maintenance medium of DMEM, 1% bovine serum albumin, penicillin, and streptomycin.
Mice.
BALB/c mice 6-8 weeks old were purchased from Charles River Breeding Laboratories (Wilmington, MA) and used within 6 weeks.
Cytokines. IL-12 was kindly supplied by Dr. M. K. Gately (Hoffmann-La Roche, Nutley, NJ), and the IL-4 was purchased from Oncor (Gaithersburg, MD) or provided by Dr. S. Narula, Schering-Plough (Kenilworth, NJ).
Virus infectivity titration in tissue culture. Virus stocks, as well as lungs, were titrated by infection of MDCK cells, as described elsewhere [43] . Infectivity titers were performed in triplicate on lungs removed from 5 individual mice at each time point and reported as log 10 TCID 50 /25 mL of lung homogenate.
Aerosol infections of mice. For in vivo experiments, 8-to 10-week old BALB/c mice were infected in an aerosol chamber, as described elsewhere [44] .
In vitro restimulation of spleen cells from immunized mice. Naïve, gamma-irradiated spleen cells infected with PR8 virus at an MOI of 1 and incubated for 60 min at 37ЊC were used as stimulator cells. Responder cells were prepared from spleens of immunized mice, and 5-day cultures were set up as described elsewhere [19] . In all experiments, groups of 5 mice were used, and the spleen of each animal was cultured individually.
Cytotoxicity assays with spleen cells from influenza virus-infected mice. After 5 days, spleen cultures were spun down and the viable cells counted and mixed with PR8 virus-infected or -uninfected P815 cells at various effector-to-target ratios, as described elsewhere [19] .
Virus inactivation. For immunization, X31 virus (H3N2) was diluted 1 : 4 in maintenance medium, and half was subjected to 6 min of UV irradiation on ice at a distance of 6 inches, followed by a 30-min incubation at 37ЊC, , after which the pH was pH ϭ 5.0 adjusted to that of the live virus. In addition to destroying all demonstrable infectivity, this method of inactivation abolished all fusogenic activity as defined by hemolysis assay [45] . Live virus had an infectivity titer in MDCK cells of 10 7 TCID 50 in 25 mL, whereas inactivated virus demonstrated no infectivity at a 10 Ϫ1 dilution either in MDCK cells or in eggs.
Immunizations. Immunizations were performed by injecting 200 mL of live ( TCID 50 /mouse) or an equivalent amount 7 2 ϫ 10 of inactivated X-31 virus, intraperitoneally. In some experiments, animals were reimmunized 2 weeks later in an identical fashion. IL-12 (10 ng/mouse) in 0.1% BALB/c serum with or without 100 mg of anti-IL-4 (11B11) was injected immediately after the virus preparation and daily for the next 3 days by intraperitoneal injection.
Cytokine determinations: IL-4 radioimmunoassay (RIA). Capture RIA was used to measure IL-4 in culture supernatants, as described elsewhere [19] .
g-interferon ELISA. Capture ELISA was used to determine the concentration of g-interferon in supernatants by use of antibody pairs purchased from Becton Dickinson (Mountain View, CA), following the manufacturer's protocol, as described elsewhere [19] .
Immunoglobulin detection. Detection of anti-influenza virus IgG1 and IgG2a antibodies in serum from naïve, as well as influenza virus-infected, mice was performed by ELISA by use of purified influenza virus at 25 mg/mL to coat plates overnight at 4ЊC, as described elsewhere [19] .
Antibody concentrations were determined by interpolation from a standard curve generated by use of monoclonal anti-influenza antibodies of the appropriate isotype.
Statistical analysis. Degrees of significance between groups of animals were determined by use of the t test and a paired 2-sample for means.
Results

Does inactivated virus prime for Th2 memory responses?
BALB/c mice were immunized with live X-31 influenza virus, inactivated X-31 virus, inactivated virus plus IL-12, and anti-IL-4 antibody, or the animals were left unimmunized. Two weeks later, the immunization protocols were repeated. No adjuvant was used. Two weeks after the last immunization, the mice were killed; their spleens were removed and restimulated in vitro with PR8 virus-infected syngeneic stimulator cells, and cytokines were collected and analyzed daily. Results are shown in figure 1A and 1B. In figure 1A , it can be seen that spleen cells from animals immunized with live virus produced significantly more g-interferon than spleen cells from animals vaccinated with inactivated virus. This could represent a weaker response to the inactivated virus inoculum, but, as shown in figure 1B , this is not the case. Spleen cells from animals immunized with inactivated virus produced large amounts of IL-4 upon restimulation with virus-infected spleen cells. Spleen cells from live virus-immunized animals produced only small amounts of IL-4. These data suggest that inactivated virus immunization primed for a Th2 type response, whereas live virus elicited a Th1 response. Interestingly, the addition of the Th1-inducing cytokine, IL-12, and neutralizing antibody to IL-4 to the inactivated virus during immunization primed for a cytokine response more similar to the response to live virus.
What antibody isotypes are generated in response to live and inactivated virus? Sera from the animals were tested for influenza virus-specific antibody. Both live and inactivated virus immunization led to the production of significant quantities of virus-specific antibodies. The sera were then analyzed by ELISA to determine the quantities of virus-specific IgG1 and IgG2a, and the results are shown in table 1. The results are reported as mg/mL of each isotype and as the ratio of IgG1 to IgG2a, calculated in the third column. It is clear that live virus induced a high level of IgG2a and much less IgG1. In contrast, inactivated virus elicited almost 3 times as much IgG1 as IgG2a. When IL-12 and anti-IL-4 were added to the immunizing inoculum, however, the inactivated virus elicited an IgG1/IgG2a ratio closely resembling that observed with live virus.
These data suggest that live virus elicits a Th1 memory response, whereas inactivated virus expands T cells that, upon restimulation, release Th2 cytokines. Moreover, the addition of IL-12 and anti-IL-4 to the inactivated virus immunization changed the response elicited by inactivated virus to a Th1-type response.
Are CTLs generated by immunization when inactivated virus is given with IL-12 and anti-IL-4?
Not surprisingly, spleen cells from animals immunized with live virus and restimulated in vitro for 5 days showed very good cytotoxic T cell activity, whereas spleen cells from those vaccinated with inactivated virus failed to generate any CTLs, as shown by the data in figure 2. Animals immunized with inactivated virus, IL-12, and anti-IL-4, while expanding Th1 T cells, nevertheless failed to generate CTLs. This suggests that generating Th1 T cells is not sufficient to lead to the expansion of the CTL precursors and probably reflects a failure of inactivated virus to enter the endogenous antigen pathway.
Can we observe heterosubtypic immunity in mice immunized with inactivated virus in the proper cytokine context? Animals immunized with live virus of one subtype and challenged by infection with a serologically distinct virus subtype demonstrate a facilitated virus clearance dependent on the presence of virusspecific T cells [30] . This phenomenon is known as heterosubtypic immunity. Inactivated virus cannot prime for heterosubtypic immunity [2, 12, 38, 39 ]. Thus, we tested whether animals immunized with inactivated virus (X-31 H3N2) and IL-12 with anti-IL-4 antibody were able to mediate heterosubtypic immunity upon infection with a serologically distinct virus subtype (PR8 H1N1). The results are shown in table 2.
In both experiments, mice immunized with live X-31 virus demonstrated lower virus titers in the lungs, compared with naïve mice. Similarly, pulmonary virus titers were lower in mice immunized with inactivated virus and IL-12 with anti-IL-4. It should be pointed out that in both experiments, lower lung virus titers were observed in mice immunized with inactivated virus and IL-12 and anti-IL-4 antibody than in mice immunized with inactivated virus alone. Moreover, it should be emphasized that IL-12 and anti-IL-4 are given only during the immunization phase in this study, and injection of IL-12 into nonimmunized animals during virus infection has no positive effect on recovery (data not shown)
Does the immunization lead to memory cell imprinting that is reactivated after challenge infection?
In the earlier experiments (figures 1A, 1B, and 2), animals were tested after immunization but prior to infection, to determine the predominant CD4 ϩ T cell populations being expanded. To determine what might be occurring in spleens of immunized mice after infection, the mice were kiled 7 days after infection; their spleens were removed and restimulated, and cultures were monitored for the presence of IL-4 and g-interferon. Interestingly, the highest production of g-interferon was by spleen cells from animals vaccinated with inactivated virus, IL-12, and anti-IL-4 antibody, and the lowest production was from spleen cells from animals immunized with inactivated virus ( figure 3A) . In contrast to these results, only spleen cells from animals immunized with inactivated virus alone produced IL-4 upon in vitro restimulation ( figure 3B) . Thus, immunization with the different forms of the virus seems to have imprinted immunological memory, resulting in the generation of Th1 response to inactivated virus when given with IL-12 and anti-IL-4 and to live virus. In contrast, animals immunized with inactivated virus alone continued to make a Th2 response even after live virus infection.
When restimulated cells were tested for cytotoxic activity, we observed that spleen cells from live virus-immunized animals had significant cytotoxic activity even at low effector-to-target cell ratios, whereas neither spleen cells from unimmunized mice nor cells from mice vaccinated with inactivated virus had any demonstrable CTL activity (figure 4). Interestingly, spleen cells from animals immunized with inactivated virus in the Th1 cytokine context showed more rapid generation of CTLs.
Discussion
Inactivated virus vaccines have been demonstrated to be useful in generating antibody responses that provide protection against homosubtypic virus infection. No evidence exists demonstrating that inactivated virus is capable of priming for T cell immunity capable of facilitating the clearance of a heterosubtypic virus challenge. Indeed, earlier studies prior to identification of the Th1 and Th2 subsets showed that in some instances, inactivated virus immunization was actually detri- The spleen cells were restimulated individually with live virus-infected cells, and after 5 days of culture, cytotoxicity was determined in a 51 chromium release assay using virus-infected P815 as targets. Cytotoxicity against uninfected P815 was !3% and was subtracted from the values. Animals in this experiment were immunized on 2 occasions, 2 weeks apart. Naïve mice were unimmunized but were challenged by live virus infection. Cytotoxicities of cultures from animals immunized with inactivated virus, interleukin (IL)-12, and anti-IL-4 were significantly different from those of both naïve and inactivated virus-immunized animals (**, ; *, ).
mental to recovery when analyzed by adoptive transfer [12] and in other studies failed to have any effect [38, 39, 46] . Experimental models of RSV infection in animals immunized with inactivated virus have demonstrated similar results [40, 41] . One explanation for this failing was that inactivated virus could not enter the endogenous pathway, leading to the generation of virus-specific CD8 ϩ memory T cells capable of killing virusinfected cells. While this may indeed be an important contributing factor, the results must be juxtaposed with a significant body of data showing that CD4 ϩ T cells infused into naïve virus-infected animals facilitate rapid and effective clearance of virus [4, 7, 8, 11, 47] . Evidence strongly suggests that to be effective, the CD4 ϩ T cells expanded must be of the Th1 type [11, 19] . Recent results from Graham and Braciale reaffirm the ability of CD4 ϩ T cells to mediate recovery and showed that the effect is only partially mediated by accelerated production of antibodies. They speculated that accelerated generation of CTLs might constitute a major contribution of the CD4 ϩ cells [4] .
Many studies have documented the ability of the cytokines IL-12 and IL-4 to induce Th1 and Th2 immunity, respectively [15, 17, 23, 28] . Evidence has accumulated suggesting that live virus leads to the release of IL-12 from dendritic cells, culminating in the generation of Th1 cells and CTLs and the subsequent clearance of virus from infected cells [48] [49] [50] [51] . Antibodies capable of neutralizing homosubtypic virus infection are generated as well. Inactivated virus is able to generate a protective antibody response but has never been shown to mediate heterosubtypic immunity. One explanation for this may be that, in addition to failing to generate CTLs, inactivated virus induces the wrong type of cellular immune response, that is, Th2 immunity. If this is indeed true, the addition of cytokines that convert the response to inactivated virus to a Th1 response may lead to the generation of memory cells capable of providing heterosubtypic protection. Support for this contention using a homotypic RSV model of infection has been published [42] .
In this report, we demonstrate that inactivated influenza virus immunization does indeed expand Th2 cells, leading to the production of IL-4 and virus-specific antibodies of the IgG1 type. Heterosubtypic challenge of these animals shows no evidence of facilitated recovery from infection, in contrast to the rapid clearance of challenge virus from live virus-immunized mice. Interestingly, when animals were vaccinated with IL-12, anti-IL-4, and inactivated virus, we repeatedly observed significantly more rapid clearance of heterosubtypic virus from lungs after live virus challenge. This strongly correlated with our observation that the addition of IL-12 and anti-IL-4 converted the immune response to a Th1 response, as exemplified by the release of g-interferon but not IL-4 from cells restimulated in vitro with virus-infected stimulator cells. No CTLs were present prior to virus infection, but virus-specific serum IgG1/IgG2a ratios were equivalent to those observed after live virus immunization. Thus, in the proper cytokine context, inactivated virus can stimulate Th1 immunity and facilitate clearance of heterosubtypic virus challenge. Heterosubtypic immunity after immunization with inactivated virus has not been reported previously. Hence, these observations may have important implication for the potential use of inactivated virus vaccines in a number of situations, such as human immunodeficiency virus or herpesvirus infections. However, it must be emphasized that, although animals immunized with a combination of inactivated virus and IL-12 and anti-IL-4 cleared heterosubtypic virus more rapidly than controls, they were not as effective in clearing virus as mice immunized with live virus. It is likely that these differences reflect the generation of CTL precursors in mice immunized with live virus, whereas in mice immunized with inactivated virus plus IL-12 and anti-IL-4, no CTL precursors were observed prior to heterosubtypic virus challenge.
Prior to infection, our immunization protocols using live and inactivated virus led to Th1 or Th2 responses, respectively. However, we felt that it was important to determine whether this imprinting would effect memory responses following virus infection. To investigate this, we removed spleen cells from animals 7 days after infection. Spleen cells from animals infected after immunization with inactivated virus plus IL-12 and anti-IL-4 antibody maintained the Th1 phenotype, whereas those immunized with inactivated virus alone made a clear Th2 response. Interestingly, CTLs were observed to appear more rapidly in animals receiving inactivated virus vaccine, IL-12, and anti-IL-4 antibody, a result reported recently in a different model system [52] . This finding suggests that a possible mechanism for the heterosubtypic immunity demonstrated in these animals is a facilitated generation of virus-specific CD8 ϩ T cells. Moreover, these data show not only that different CD4 ϩ phenotypes are generated with the various forms of virus but also that the memory T cell response is imprinted and responds accordingly.
The presence of IL-12 during induction converts the response to Th1, consistent with the theory that IL-12-producing cells, probably dendritic cells, likely function to determine whether a full inflammatory response or a blocking immune response is elicited [53] . In contrast to live or dead bacteria, parasites [54] [55] [56] , or live virus [48] , which can elicit IL-12 from dendritic cells, inactivated virus may not be able to induce IL-12 release.
Indeed, in our laboratory, we have observed that live virus but not inactivated virus can activate an IL-12 promoter construct in DC 2.4 cells (data not shown).
We do not mean to imply that inactivated virus plus IL-12 and anti-IL-4 would be superior to the currently employed trivalent influenza virus vaccine, but the data suggest that a renewed interest in inactivated virus vaccines may be warranted. If engineered to create the correct cytokine environment, they may be able to prime for some degree of cell-mediated immunity that might be crucial in host defense.
